Salomon Merikansky

Salomon Merikansky

Auto-generated profile, based on publicly available information

Salomon Merikansky

From the Department of Ophthalmology (F.E.T., H.D., A.R.L., M.C.A., S.M., H.W.F., G.A.), Bascom Palmer Eye Institute, Ophthalmic Biophysics Center, University of Miami Miller School of Medicine, Miami, Florida, USA; Department of Ophthalmology (A.A., S.M., M.H., J.M.M., H.W.F., G.A., D.M.), Bascom Palmer Eye Institute, Ocular Microbiology Laboratory, University of Miami Miller School of Medicine, Miami, Florida, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of Dental Anesthesia and Pain Medicine
Verified
Journal Article
Open access
PDF file
PRPablo Gomes-Da Silva de Rosenzweig
Pablo Gomes-Da Silva de Rosenzweig
SBSantiago Pastrana Brandes
Santiago Pastrana Brandes
SMSalomon Merikansky-Gerson
Salomon Merikansky-Gerson
LVLuis Octavio Victoria-Garcia
Luis Octavio Victoria-Garcia
MCMagdalena Sophia Curtius-Caruso
Magdalena Sophia Curtius-Caruso
JCJosé Damián Carrillo-Ruiz
José Damián Carrillo-Ruiz
Gomes-da Silva de Rosenzweig P, et al. J Dent Anesth Pain Med. 2024 Aug;24(4):227-243. https://doi.org/10.17245/jdapm.2024.24.4.227

5 April 2025 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Open access
SMSalomon Merikansky
Salomon Merikansky
CMCarolina Mercado
Carolina Mercado
HDHeather Durkee
Heather Durkee
RKRudolf Kobus
Rudolf Kobus
JNJuan Carlos Navia
Juan Carlos Navia
GAGuillermo Amescua
Guillermo Amescua
Purpose To report the utility of Rose Bengal Photodynamic Antimicrobial Therapy (RB-PDAT) as an adjunct treatment in rapidly progressing Infectious Necrotizing Scleritis (INS) secondary to Pseudomonas aeruginosa. Methods Retrospective chart review was conducted on consecutive patients with scleritis and culture-proven Pseudomonas aeruginosa who underwent RB-PDAT. Results Six patients with Pseudomonas aeruginosa INS were included. All patients achieved complete resolution of the infection. The mean time to resolution after RB-PDAT was 17 days (range; 6-30 days), with a total treatment course average of 36 days (range; 22-60 days). One patient with pan-resistant Pseudomonas sclerokeratitis required two RB-PDAT treatments due to persistent stromal melting. All patients received a standardized regimen of oral fluoroquinolone, topical tobramycin, and ciprofloxacin/moxifloxacin. The patient with pan-resistant Pseudomonas aeruginosa required treatment with topical imipenem as well. None of the patients required enucleation. Conclusion RB-PDAT is a feasible option to halt the progression of infectious necrotizing scleritis caused by Pseudomonas aeruginosa, especially in cases of impending perforation.

7 April 2026 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
FTFelipe Echeverri Tribin
Felipe Echeverri Tribin
HDHeather Durkee
Heather Durkee
AAAlexander Alfonso
Alexander Alfonso
ALAlison Rodriguez Leiva
Alison Rodriguez Leiva
MAMariela C. Aguilar
Mariela C. Aguilar
Darlene MillerDarlene Miller
Darlene Miller

1 December 2025 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
ENErik Navas-Villar
Erik Navas-Villar
JJJavier Jáuregui-Aguirre
Javier Jáuregui-Aguirre
DMDiego Melo-Orta
Diego Melo-Orta
ICIvonne Curiel-Arce
Ivonne Curiel-Arce
SMSalomon Merikansky
Salomon Merikansky
ACArturo Chayet
Arturo Chayet
Purpose: To evaluate the refractive and visual outcomes of pseudophakic eyes undergoing simultaneous pterygium and cataract surgery with light adjustable lens (LAL) implantation, offering a single-stage alternative to the traditional 2-stage approach. Setting: Clinical practice setting in Tijuana, Baja California, Mexico. Design: Retrospective, observational study. Methods: Eyes that underwent simultaneous pterygium and cataract removal with LAL implantation between May 2021 and August 2024 were included. The surgical protocol involved LAL calculation, pterygium excision, cataract extraction, and LAL implantation. Postoperative care included medication and refractive adjustments using the light delivery device to achieve desired refractive outcomes. Visual acuity, manifest refraction, and corneal astigmatism were assessed preoperatively, before the first LAL adjustment, and 3 months postoperatively. Results: 18 eyes from 14 patients were analyzed. Mean spherical equivalent (SEQ) improved to −0.29 diopter (D) (±0.29) at 3 months. 9 eyes (50%) achieved SEQ <0.25 D, and 15 eyes (83%) achieved SEQ <0.5 D. Mean uncorrected distance visual acuity improved to logMAR 0.096 (±0.11). Refractive astigmatism was significantly reduced, demonstrating the procedure's effectiveness in achieving favorable visual and refractive outcomes. Conclusions: Simultaneous pterygium and cataract surgery with LAL implantation offers a viable alternative for patients who face logistical challenges with the traditional 2-stage approach. The adjustability of the LAL mitigates refractive unpredictability caused by corneal irregularities. Further studies with larger sample size and longer follow-up are required to support these findings.